Implications of BRAF V600E Mutations in Pediatric Low-Grade Gliomas
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas
J. Clin. Oncol 2017 Jul 20;[EPub Ahead of Print], A Lassaletta, M Zapotocky, M Mistry, V Ramaswamy, M Honnorat, R Krishnatry, A Guerreiro Stucklin, N Zhukova, A Arnoldo, S Ryall, C Ling, T McKeown, J Loukides, O Cruz, C de Torres, CY Ho, RJ Packer, R Tatevossian, I Qaddoumi, JH Harreld, JD Dalton, J Mulcahy-Levy, N Foreman, MA Karajannis, S Wang, M Snuderl, A Nageswara Rao, C Giannini, M Kieran, KL Ligon, ML Garre, P Nozza, S Mascelli, A Raso, S Mueller, T Nicolaides, K Silva, R Perbet, A Vasiljevic, C Faure Conter, D Frappaz, S Leary, C Crane, A Chan, HK Ng, ZF Shi, Y Mao, E Finch, D Eisenstat, B Wilson, AS Carret, P Hauser, D Sumerauer, L Krskova, V Larouche, A Fleming, S Zelcer, N Jabado, JT Rutka, P Dirks, MD Taylor, S Chen, U Bartels, A Huang, DW Ellison, E Bouffet, C Hawkins, U TaboriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.